Buy Now

Hematology IM Board Review

Approach to Anemia

  • Step 1: Kinetic view

    • Low retic → ↓ production (iron, B12/folate lack, marrow failure)

    • High retic → ↑ destruction/loss (hemolysis, blood loss, splenic sequestration)

  • Step 2: Morphologic view (MCV)

    • Microcytic (< 80) → iron deficiency vs thalassemia

    • Normocytic (80-100) → early iron-def, anemia of inflammation, CKD, hemolysis

    • Macrocytic (> 100) → B12/folate lack, MDS, liver, alcohol, drugs

 

Microcytic Anemia Essentials

  • Iron deficiency

    • Buzz: pica, restless legs, low ferritin (< 40); reactive thrombocytosis common

    • Must do: search for occult blood → EGD/colonoscopy

  • Anemia of inflammation (chronic disease)

    • High ferritin, low TIBC, low/normal iron sat; treat underlying cause ± EPO

  • Thalassemia traits

    • Disproportionately low MCV (eg 55) with mild anemia

    • ÎČ-trait: ↑ HbA₂ on electrophoresis. α-trait: normal electrophoresis

    • Never give iron unless deficient

 

Macrocytic Anemia Essentials

  • B12 deficiency

    • Clues: neuropathy, other autoimmune disease, pernicious anemia (IF Ab)

    • Borderline B12? Check MMA + homocysteine (both ↑)

  • Folate deficiency

    • Clues: alcoholism, pregnancy, rapid cell turnover, MTX

    • Only homocysteine ↑ (MMA normal). No neurologic signs

  • Smear hallmark: macro-ovalocytes + hypersegmented neutrophils

 

Hemolytic Anemias

Bucket Examples Key lab / smear Special pearls
Intrinsic (hereditary) Sickle cell, thalassemia major, G6PD, hereditary spherocytosis, PNH ↑ LDH, ↑ indirect bili, ↓ haptoglobin, ↑ retic G6PD assay after 2–3 mo;
PNH → hemoglobinuria + thrombosis
Extrinsic (acquired) Autoimmune hemolysis (warm IgG, cold IgM), MAHA (TTP, HUS, DIC), mechanical Direct Coombs + in autoimmune only Warm → steroids;
Cold → keep warm / treat cause

Rapid identifiers

  • Hourglass spherocytes + ↑ MCHC → hereditary spherocytosis

  • Bite cells + Heinz bodies → G6PD

  • Schistocytes + normal PT/PTT → TTP/HUS

  • Schistocytes + prolonged PT/PTT → DIC

  • Clot + heparin exposure → HIT (stop heparin, start argatroban)

 

Bleeding & Clotting Framework

  • Primary hemostasis (platelets)

    • Superficial mucocutaneous bleeding

    • Low number: ITP (isolated), TTP/HUS/DIC/HIT (plus hemolysis)

    • Poor function: von Willebrand disease → prolonged bleeding time ± PTT; treat with DDAVP

  • Secondary hemostasis (coag factors)

    • Deep soft-tissue / hemarthrosis

    • Interpret PT/PTT + mixing study

      • PT only ↑ → factor VII/VK/Liver/Warfarin

      • PTT only ↑ → factors VIII, IX, XI, XII or inhibitor

      • Mix corrects → deficiency (eg hemophilia A)

      • Mix fails → inhibitor (APLS if clot; acquired VIII inhibitor if bleed)

    • Oddballs

      • Normal labs yet bleed → factor XIII defect

      • High PTT, no bleed → factor XII defect

 

Transfusion Reactions (know the calls)

Time Presentation Diagnosis / Key test Action
Minutes Fever, flank pain Acute hemolytic (ABO) w/ + direct Coombs Stop transfusion, vigorous support
Minutes Fever only Febrile non-hemolytic Stop, then acetaminophen ± restart
Hours Dyspnea TRALI (non-cardiogenic) vs TACO (volume) - BNP/JVD help differentiate TRALI: stop + oxygen; TACO: diurese
Days Jaundice, ↓ Hgb Delayed hemolytic (Rh) Supportive

 

Bone Marrow & Hematologic Malignancies

  • Aplastic anemia →  young, pancytopenia, hypocellular marrow; treat with transplant or ATG/cyclosporine

  • Myelodysplastic syndrome (MDS) →  older, pancytopenia, hypercellular dysplastic marrow; risk AML; 5q- deletion responds to lenalidomide

  • Acute leukemias

    • AML: blasts > 20 %, ± auer rods (M3/APL t(15;17)→ treat with ATRA; watch DIC)

    • ALL: blasts + CNS, nodes, hepatosplenomegaly; common in children

    • Hyperleukocytosis → leukostasis → emergent leukapheresis

  • Myeloproliferative neoplasms

    • CML: very high WBC with all myeloid stages; t(9;22) (BCR-ABL); treat with TKIs (imatinib etc)

    • Polycythemia vera & Essential thrombocythemia: JAK2+ (≈100 % PV, 50 % ET); treat phlebotomy or hydroxyurea

  • Chronic lymphocytic leukemia (CLL)

    • Elderly, asymptomatic lymphocytosis + smudge cells; observe unless symptomatic; Richter transformation risk

  • Lymphomas

    • Aggressive (DLBCL, Burkitt) → symptomatic; curable with chemo (R-CHOP, high-grade regimens)

    • Indolent (follicular, marginal zone)→ often watch-and-wait

    • Hodgkin: Reed-Sternberg “owl-eye” cells; ABVD; late toxicities (CAD, hypothyroid)

  • Plasma-cell disorders

    • Multiple myeloma: CRAB signs, M-spike on SPEP/UPEP, rouleaux; treat with chemo ± ASCT, bisphosphonates

    • MGUS (< 3 g/dL, < 10 % plasma cells, no CRAB)→ yearly follow-up

    • Waldenström (IgM spike) → hyperviscosity; consider plasmapheresis

 

High-Yield One-Liners

  • Iron-deficiency with platelets > 450 k  → reactive thrombocytosis, not leukemia

  • Sickle cell crisis + low retic → aplastic crisis (parvovirus B19)

  • Splenic sequestration crisis occurs in SC disease, not SS

  • Platelets < 30 k + bleeding → treat ITP (steroids IVIg); don’t transfuse unless life-threatening bleed

  • Never give platelets in TTP or HIT

  • Pregnant DVT → treat with low-molecular-weight heparin

  • Back pain, anemia, creatinine rise, total protein ↑ → order SPEP + UPEP for myeloma work-up